TherapeuticsMD (TXMD) Intangibles (2012 - 2026)
TherapeuticsMD (TXMD) reported Intangibles of $3.56 million for Q2 2026, down 12.0% from $4.04 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Intangibles (2012 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD posted Intangibles of $3.76 million, down 13.0% from FY2024.
- Intangibles has declined for five consecutive years, with a five-year compound annual growth rate of -38.1% (FY2020 to FY2025).
- By year, Intangibles came in at $4.32 million in FY2024 (-29.1%), $6.1 million in FY2023 (-12.2%), $6.94 million in FY2022 (-2.8%) and $7.14 million in FY2021 (-82.8%).
- The Q2 2026 figure ranks as the lowest quarterly Intangibles since Q2 2018.
- Year over year, Intangibles has now declined in each of the last 19 quarters, with an average decline of 19.0% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q3 2021 (growth of 615.4%); the low point was Q4 2021 (a decline of 82.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.67 million (Q1 2026), $3.76 million (Q4 2025) and $3.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 3.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.56 Mn |
| Mar 31, 2026 | 3.67 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 4.04 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 4.32 Mn |
| Sep 30, 2024 | 4.43 Mn |
| Jun 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 5.97 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Jun 30, 2023 | 6.77 Mn |
| Mar 31, 2023 | 6.88 Mn |
| Dec 31, 2022 | 6.94 Mn |
| Sep 30, 2022 | 37.88 Mn |
| Jun 30, 2022 | 38.72 Mn |
| Mar 31, 2022 | 39.55 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 39.62 Mn |
API Access
TherapeuticsMD Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();